文献速递精神分裂症与精神病性障碍

精神分裂症内表型的全基因组关联研究:COGS 研究

Genome-wide Association of Endophenotypes for Schizophrenia From the Consortium on the Genetics of Schizophrenia (COGS) Study.
PubMed 文献 · JAMA Psychiatry · 2019-01-01

该研究在COGS-2独立队列中对1789名精神分裂症患者和健康对照的11个神经生理与神经认知内表型进行全基因组关联分析,最终1533人纳入分析,识别出7个全基因组显著区域和2个接近显著区域,涉及NRG3、HCN1等基因,并显示与COGS-1结果及精神分裂症诊断区域广泛重叠。

要点

  • 在COGS-2队列中,11个精神分裂症相关内表型共识别7个全基因组显著区域(P<5×10-8)和2个接近显著区域(P<9×10-8)。
  • 显著区域包含NRG3、HCN1等候选基因,且与COGS-1家系关联结果及精神分裂症诊断区域广泛重叠。
  • 内表型有助于解析精神分裂症遗传结构,并可能为精准医学和新型治疗靶点提供线索。

核心结论

  • 研究识别出多个需进一步探索和验证的基因组区域,提示内表型有助于解析精神分裂症的遗传结构并表征潜在生物学功能障碍。

研究设计与样本

  • 按诊断和 ancestry 分层,采用线性回归调整年龄、性别和5个主成分,并通过加权荟萃分析合并结果。
  • COGS-1数据收集于2003年1月6日至2008年8月6日,COGS-2数据收集于2010年6月30日至2014年2月14日,数据分析于2016年10月28日至2018年5月4日。

主要发现

  • 最终样本1533人,其中男性861人(56.2%),平均(SD)年龄41.8(13.6)岁。
  • 共识别7个全基因组显著区域(P<5×10-8)和2个接近显著区域(P<9×10-8),涵盖NRG3、HCN1等基因,涉及7个内表型。
  • 在P<10-4水平,11个内表型的富集分析结果与COGS-1家系既往关联结果吻合,并与精神分裂症诊断识别区域广泛重叠。

关键数值与推荐

  • 全基因组显著性阈值定义为P<5×10-8,接近显著阈值定义为P<9×10-8。
  • 富集分析在P<10-4水平进行,并与COGS-1家系关联结果及精神分裂症诊断区域比较。

临床怎么用

  • 内表型可作为解析精神分裂症遗传结构和生物学功能障碍的辅助工具,但当前发现的基因组区域尚需进一步验证,暂不能直接用于临床决策。

局限性

  • 原文未报告局限性相关内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The Consortium on the Genetics of Schizophrenia (COGS) uses quantitative neurophysiological and neurocognitive endophenotypes with demonstrated deficits in schizophrenia as a platform from which to explore the underlying neural circuitry and genetic architecture. Many of these endophenotypes are associated with poor functional outcome in schizophrenia. Some are also endorsed as potential treatment targets by the US Food and Drug Administration. OBJECTIVE: To build on prior assessments of heritability, association, and linkage in the COGS phase 1 (COGS-1) families by reporting a genome-wide association study (GWAS) of 11 schizophrenia-related endophenotypes in the independent phase 2 (COGS-2) cohort of patients with schizophrenia and healthy comparison participants (HCPs). DESIGN, SETTING, AND PARTICIPANTS: A total of 1789 patients with schizophrenia and HCPs of self-reported European or Latino ancestry were recruited through a collaborative effort across the COGS sites and genotyped using the PsychChip. Standard quality control filters were applied, and more than 6.2 million variants with a genotyping call rate of greater than 0.99 were available after imputation. Association was performed for data sets stratified by diagnosis and ancestry using linear regression and adjusting for age, sex, and 5 principal components, with results combined through weighted meta-analysis. Data for COGS-1 were collected from January 6, 2003, to August 6, 2008; data for COGS-2, from June 30, 2010, to February 14, 2014. Data were analyzed from October 28, 2016, to May 4, 2018. MAIN OUTCOMES AND MEASURES: A genome-wide association study was performed to evaluate association for 11 neurophysiological and neurocognitive endophenotypes targeting key domains of schizophrenia related to inhibition, attention, vigilance, learning, working memory, executive function, episodic memory, and social cognition. RESULTS: The final sample of 1533 participants included 861 male participants (56.2%), and the mean (SD) age was 41.8 (13.6) years. In total, 7 genome-wide significant regions (P < 5 × 10-8) and 2 nearly significant regions (P < 9 × 10-8) containing several genes of interest, including NRG3 and HCN1, were identified for 7 endophenotypes. For each of the 11 endophenotypes, enrichment analyses performed at the level of P < 10-4 compared favorably with previous association results in the COGS-1 families and showed extensive overlap with regions identified for schizophrenia diagnosis. CONCLUSIONS AND RELEVANCE: These analyses identified several genomic regions of interest that require further exploration and validation. These data seem to demonstrate the utility of endophenotypes for resolving the genetic architecture of schizophrenia and characterizing the underlying biological dysfunctions. Understanding the molecular basis of these endophenotypes may help to identify novel treatment targets and pave the way for precision-based medicine in schizophrenia and related psychotic disorders.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Greenwood TA, Lazzeroni LC, Maihofer AX, et al. Genome-wide Association of Endophenotypes for Schizophrenia From the Consortium on the Genetics of Schizophrenia (COGS) Study. JAMA Psychiatry. 2019. PMID: 31596458. doi:10.1001/jamapsychiatry.2019.2850

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。